Heart Failure Clinical Trials in Boston, Massachusetts

29 studies are recruiting for heart failure in Boston, Massachusetts right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies, page 2

  1. Left vs Left Randomized Clinical Trial

    The investigators aim to prospectively test the comparative effectiveness of His or Left bundle branch pacing in relation to patient centered outcomes (quality of life, physical activity, heart failure hospitalization, mortality) and comparative safety in relation to device-related complications an…

    Stage
    Not phased
    Ages
    18 and older
    Site
    Massachusetts General Hospital, Boston, Massachusetts
    Locations
    71 in total
    Run by
    Baylor College of Medicine
  2. A Multi-center, National, Open-label, Prospective Study to Evaluate the Performance of the V-Lap™ System

    The objective of this study is to evaluate the safety and performance of the V-LAP System in subjects with New York Heart Association (NYHA) functional class II and III HF, irrespective of left ventricular ejection fraction.

    Stage
    Not phased
    Ages
    22 to 88
    Site
    One Boston Medical Center Place, Boston, Massachusetts
    Run by
    Vectorious Medical Technologies Ltd.
  3. Changes in Skeletal Muscle Thickness in Patients With Acute Heart Failure

    This study aims to determine, via skeletal muscle ultrasound (US), the extent, timing and relationship between skeletal muscle mass loss and outcomes after orthotropic heart transplantation (OHT) and left ventricular assist device (LVAD) implantation amongst patients with cardiogenic shock. Advance…

    Stage
    Not phased
    Ages
    18 to 100
    Site
    Tufts Medical Center, Boston, Massachusetts
    Run by
    Tufts Medical Center
  4. Identification of Genomic Predictors of Adverse Events After Cardiac Surgery

    This study aims to identify genetic causes of adverse events after cardiac surgery, such as atrial fibrillation, myocardial infarction, renal dysfunction and heart failure. Patients undergoing heart surgery at Brigham and Women's Hospital and Texas Heart Institute are eligible to participate.

    Stage
    Not phased
    Ages
    20 to 90
    Site
    Brigham and Women's Hospital, Boston, Massachusetts
    Locations
    3 in total
    Run by
    Brigham and Women's Hospital

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.